Pegfilgrastim biosimilar (PharmaEssentia)

培非司亭生物类似药 (PharmaEssentia)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (PharmaEssentia)

Drug Alias Name培非司亭生物仿制药 (PharmaEssentia)非格司亭生物仿制药 (PharmaEssentia)PEG-GCSF

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPharmaEssentia Corp

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNeutropenia

ATC CodeL03AA13